Zurcher Kantonalbank (Zurich Cantonalbank) Erasca, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$1.67 - $2.49 $7,266 - $10,833	-4,351 Reduced 12.64%	30,070 $64,000
Q3 2023 Oct 25, 2023	BUY	$1.97 - $2.91 $45,759 - $67,593	23,228 Added 207.52%	34,421 $67,000
Q1 2023 May 08, 2023	BUY	$2.74 - $4.44 $11,921 - $19,318	4,351 Added 63.59%	11,193 $33,000
Q4 2022 Feb 01, 2023	SELL	$3.89 - $8.57 $22,884 - $50,417	-5,883 Reduced 46.23%	6,842 $29,000
Q3 2022 Nov 09, 2022	BUY	$5.82 - $10.68 $45,739 - $83,934	7,859 Added 161.51%	12,725 $99,000
Q2 2022 Aug 09, 2022	BUY	$4.58 - $8.72 $22,286 - $42,431	4,866 New	4,866 $27,000

Others Institutions Holding ERAS

# of Institutions

140

Shares Held

229M

Call Options Held

28.7K

Put Options Held

117K

Frazier Life Sciences Management, L.P. Menlo Park, CA

19.4M
Shares

$46 Million
2.85% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

16.8M
Shares

$39.9 Million
0.03% of portfolio
Vr Adviser, LLC New York, NY

16.2M
Shares

$38.4 Million
4.58% of portfolio
Suvretta Capital Management, LLC New York, NY

13.8M
Shares

$32.6 Million
1.48% of portfolio
Vanguard Group Inc Valley Forge, PA

13.3M
Shares

$31.5 Million
0.0% of portfolio

View Full List

About Erasca, Inc.

Ticker ERAS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 122,147,000
Market Cap $289M
Description
Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...

More about ERAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account